Current evaluation of the millennium phytomedicine - Ginseng (II): Collected chemical entities, modern pharmacology, and clinical applications emanated from traditional chinese medicine

Current Medicinal Chemistry

Volumn 16, Issue 22, 2009, Pages 2924-2942

  Jia, Lee ^a,d   Zhao, Yuqing ^b   Liang, Xing Jie ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^c NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

^d NONE   (United States)

Author keywords

Anti apoptosis; Aphrodisia; Diabetics; Ginseng; Ginsenosides; Neuropharmacology; Nitric oxide; Phytomedicine

Indexed keywords

CYCLIC AMP; CYCLIC GMP; CYCLOPHOSPHAMIDE; GINSENG EXTRACT; GINSENOSIDE; GINSENOSIDE RB 1; GINSENOSIDE RG 1; GINSENOSIDE RG 3; GINSENOSIDE RH 2; GLUCOSE; INDINAVIR; INSULIN; MALONALDEHYDE; NITRIC OXIDE;

ANTIANGIOGENIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANXIETY; CARDIOVASCULAR EFFECT; CHINESE MEDICINE; COGNITION; COMBINATION CHEMOTHERAPY; CONFUSION; DEPERSONALIZATION; DEPRESSION; DIABETES MELLITUS; DIARRHEA; DRUG ABSORPTION; DRUG EFFICACY; DRUG OVERDOSE; DRUG SAFETY; EPISTAXIS; EUPHORIA; GASTROINTESTINAL SYMPTOM; GINSENG; GLUCOSE BLOOD LEVEL; HEADACHE; HUMAN; HYPERTENSION; INSOMNIA; INSULIN BLOOD LEVEL; LIPID PEROXIDATION; MALIGNANT NEOPLASTIC DISEASE; MASTALGIA; MONOTHERAPY; NERVOUSNESS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OVARY CANCER; PARKINSON DISEASE; PHYTOCHEMISTRY; RASH; RECTUM CANCER; REVIEW; SEXUAL BEHAVIOR; SIDE EFFECT; SOMNOLENCE; TRADITIONAL MEDICINE; VAGINA BLEEDING; VOMITING;

ANIMALS; APHRODISIACS; DIABETES MELLITUS; HUMANS; NEOPLASMS; NEUROPHARMACOLOGY; PANAX; PHYTOTHERAPY; PLANT PREPARATIONS;

EID: 70349408655     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986709788803204     Document Type: Review

References (181)

1. Jiang, J.W.; Xiao, Q.S. Handbook of active constituents of medicinal plants. People's Health Publisher: Beijing, 1985; pp. 503-516.
2. Park, E.K.; Shin, Y.W.; Lee, H.U. Inhibitory effect of ginsenoside Rb1 and compound K on NO and prostaglandin E2 biosynthesis of RAW264.7 cells induced by lipopolysaccharide. Bio. Pharm. Bull., 2005, 28, 652-656.
3. Lee, Y.J.; Jin, Y.R.; Lim, W.C. Ginsenoside-Rb1 acts as a weak phytoestrogen in MCF-7 human breast cancer cells. Arch. Pharm. Res., 2003, 26, 58-63.
4. Fujimoto, J.; Sakaguchi, H.; Aoki, I. Inhibitory effect of ginsenoside-Rb2 on invasiveness of uterine endometrial cancer cells to the basement membrane. Eur. J. Gynecol. Oncol., 2001, 22, 339-41.
5. Liu, Z.Q.; Luo, X.Y.; Sun, Y.X. Can ginsenosides protect human erythrocytes against free-radical-induced hemolysis. Biochim. Biophys. Acta., 2002, 1572, 58-66.
6. Liu, Z.Q.; Luo, X.Y.; Liu, G.Z. In vitro study of the relationship between the structure of ginsenoside and its antioxidative or prooxidative activity in free radical induced hemolysis of human erythrocytes. J. Agric. Food Chem., 2003, 51, 2555-2558.
7. Surh, Y.J.; Lee, J.Y.; Choi, K.J.; Ko, S.R. Effects of selected ginsenosides on phorbol ester-induced expression of cyclooxygenase-2 and activation of NF-kappaB and ERK1/2 in mouse skin. Ann. N. Y. Acad. Sci., 2002, 973, 396-401.
8. Berek, L.; Szabo, D.; Petri, I.B.; Shoyama, Y.; Lin, Y.H.; Molnar, J. Effects of naturally occurring glucosides, solasodine glucosides, ginsenosides and parishin derivatives on multidrug resistance of lymphoma cells and leukocyte functions. In Vivo., 2001, 15, 151-156.
9. Keum, Y.S.; Han, S.S.; Chun, K.S.; Park,K.K.; Park, J.H.; Lee, S.K.; Surh,Y.J. Inhibitory effects of the ginsenoside Rg3 on phorbol ester-induced cyclooxygenase-2 expression, NF-kB activation and tumor promotion. Mutat. Res., 2003, 523, 75-85.
10. Popovich, D.G.; Kitts, D.D. Structure-function relationship exists for ginsenosides in reducing cell proliferation and inducing apoptosis in the human leukemia (THP-1) cell line. Arch. Biochem. Biophys., 2002, 406, 1-8.
11. Bae, E. A.; Han, M. J.; Kim, E. J. Transformation of ginseng saponins to ginsenoside Rh2 by acids and human intestinal bacteria and biological activities of their transformants. Arch. Pharmacol. Res., 2004, 27, 61-67.
12. Kim, Y.S.; Jin, S.H. Ginsenoside Rh2 induces apoptosis via activation of caspase-1 and -3 and up-regulation of Bax in human neuoblastoma. Arch. Pharm. Res., 2004, 27, 834-839.
13. Kim, S.E.; Lee, Y.H.; Park, J.H. Ginsenoside-Rs4, a new type of ginseng saponin concurrently induces apoptosis and selectively elevates protein levels of p53 and p21WAF1 in human hepatoma SK-HEP-1 cells. Eur. J. Cancer, 1999, 35, 507-511.
14. Chen, J.T.; Li, H.Z.; Wang, D.; Zhang, Y.J.; Yang, C.R. New dammarane monodesmosides from the acidic deglycosylation of notoginseng-leaf saponins. Helvetica Chimica Acta, 2006, 89, 1442-1448.
15. He, K.J.; Liu, Y.; Yang, Y.; Li, P.; Yang, L. A dammarane glycoside derived from ginsenoside Rb3. Chem. Pharm. Bull., 2005, 53, 177-179.
16. Lei, J.; Li, X.; Gong, X.J.; Zheng, Y.N. Isolation, synthesis and structures of cytotoxic ginsenoside derivatives. Molecules, 2007, 12, 2140-2150.
17. Besso, H.; Kasai, R.; Wei, J.X.; Wang, J.F.; Saruwatari, Y.; Fuwa, T.; Tanaka, O. Further studies on dammarane-saponins of American ginseng, roots of Panax quinquefolium L. Chem. Pharm. Bull., 1982, 30, 4534-8.
18. Yoshikawa, M.; Murakami, T.; Yashiro, K.; Yamahara, J.; Matsuda, H.; Saijoh, R.; Tanaka, O. Bioactive saponins and glycosides. XI. Structures of new dammarane-type triterpene oligoglycosides, quinquenosides I, II, III, IV, and V, from American ginseng, the roots of Panax quinquefolium L. Chem. Pharm. Bull. 1998, 46, 647-54.
19. Wang, J.H.; Li, W.; Sha, Y.; Tezuka, Y.; Kadota, S.; Li, X. Triterpenoid saponins from leaves and stems of Panax quinquefolium L. J. Asian Nat. Prod Res., 2001, 3, 123-30.
20. Chihiro, T.; Itsuki, H.; Tomoharu, K.; Katsuko, K. Metabolite 1 of protopanaxadiol-type saponins, an axonal regenerative factor, stimulates teneurin-2 linked by PI3-Kinase cascade. Neuropsychopharmacol. 2006, 31, 1158-1164.
21. Yang, Z.G.; Sun, H.X.; Ye, Y. Ginsenoside Rd from Panax notoginseng is cytotoxic towards HeLa cancer cells and induces apoptosis. Chem. Biodiv., 2006, 3, 187-197.
22. Lee, B.H.; Lee, S.J.; Hui, J. H. In vitro antigenotoxic activity of novel ginseng saponin metabolites formed by intestinal bacteria. Planta Medica, 1998, 64, 500-503.
23. Shin, J.E.; Park, E.K. Cytotoxicity of compound K (IH-901) and ginsenoside Rh2, main biotransformants of ginseng saponins by bi-fidobacteria, against some tumor cells. J. Ginseng Res., 2003, 27, 129-134.
24. Lee, J.Y.; Shin, J.W.; Chun, K.S. Antitumor promotional effects of a novel intestinal bacterial metabolite (IH-901) derived from the protopanaxadiol type ginsenosides in mouse skin. Carcinogenesis, 2005, 26, 359-367.
25. Chen, G.T.; Yang, M.; Song, Y.; Lu, Z.Q.; Zhang, J.Q.; Huang, H.L.; Wu, L.J.; Guo, D.A. Microbial transformation of ginsenoside Rb1 by Acremonium strictum. Appl. Microbio. Biotech., 2008, 77, 1345-1350.
26. Ge, Y.C.; Liu, P.; Han, C.X. Influence of ginsenoside Rb1, Rg1, Re and Rh1 on Hela cells. Pharmacol. Clin. TCM., 1997, 13, 18-21.
27. Chen, W.Z.; Ou, Y.X.N. Study on the mechanism of ginsenoside anticancer. Fujian J. TCM., 2005, 36, 52-53.
28. Chan, R.Y.; Chen, W.F.; Dong, A. Estrogen-like activity of ginsenoside Rg1 derived from Panax notoginseng. J. Clin. Endocrinol. Metab., 2002, 87, 3691-5.
29. Lee, Y.; Jin, Y.; Lim, W. A ginsenoside-Rh1, a component of ginseng saponin, activates estrogen receptor in human breast carcinoma MCF-7 cells. J. Steroid. Biochem. Mol. Biol., 2003, 84, 463-8.
30. Teng, R.W.; Li, H.Z.; Chen, J.T.; Wang, D.Z.; He, Y.N.; Yang, C.R. Complete assignment of 1H and 13C NMR data for nine protopanaxatriol glycosides. Magnet. Reson. Chem., 2002, 40, 483- 88.
31. Matsuura, H.; Kasai, R.; Tanaka, O.; Saruwatari, Y.; Fuwa, T.; Zhou, J. Further studies on dammarane-saponins of Sanchi-Ginseng. Chem. Pharm. Bull., 1983, 31, 2281-7.
32. Li, Z.; Wu, C.F.; Pei, G.; Guo, Y.Y.; Li, X. Antagonistic effect of pseudoginsenoside-F11 on the behavioral actions of morphine in mice. Pharmacol. Biochem. Behav., 2000, 66, 595-601.
33. Li, Z.; Xu, N.J.; Wu, C.F.; Xiong, Y.; Fan, H.P.; Zhang, W.B.; Sun, Y.; Pei, G. Pseudoginsenoside-F11 attenuates morphine-induced signaling in Chinese hamster ovary-mu cells. Neuro Report, 2001, 12, 1453-1456.
34. Bao, H.Y.; Zhang, J.; Yeo, S.J.; Myung, C.S.; Kim, H.M.; Kim, J.M.; Park, J.H.; Cho, J.; Kang, J.S. Memory enhancing and neuroprotective effects of selected ginsenosides. Arch. Pharm. Res., 2005, 28, 335-342.
35. Cha, H.Y.; Park, J.H.; Hong, J.T.; Yoo, H.S.; Song, S.; Hwang, B.Y.; Eun, J.S.; Oh, K.W. Rb1, Rg1, and the Rg5 - Anxiolytic-like effects of ginsenosides on the elevated plus-maze model in mice. Biol. Pharm. Bull., 2005, 28, 1621-1625.
36. Kim, Y.S.; Kim, D.S.; Kim, S.I. Ginsenoside Rh2 and Rh3 induce differentiation of HL60 cells into granulocytes: Modulation of protein kinase C isoforms during differentiation by ginsenoside Rh2. Int. J. Biochem. Cell. Biol., 1998, 30, 327-338.
37. Chen, G.T.; Yang, M.; Lu, Z.Q.; Zhang, J.Q.; Huang, H.L.; Liang, Y.; Guan, S.H.; Song, Y.; Wu, L.J.; Guo, D.A. Microbial transformation of 20(S)-Protopanaxatriol-type saponins by Absidia coerulea. J. Nat. Prod., 2007, 70, 1203-1206.
38. Chen, G.T.; Yang. M.; Song, Y.; Lu, Z.Q.; Zhang, J.Q.; Huang, H.L.; Wu, L.J.; Guo, D.A. Microbial transformation of ginsenoside Rb1 by Acremonium strictum. Appl. Microbiol. Biotech., 2008, 77, 1345-1350.
39. Chen, J.T.; Li, H.Z.; Wang, D.; Zhang, Y.J.; Yang, C.R. New dammarane monodesmosides from the acidic deglycosylation of notoginseng-leaf saponins. Helvetica Chimica Acta, 2006, 89, 1442-1448.
40. Zhang, X.R.; Zhang, D.; Xu, J.H.; Gu, J.K.; Zhao, Y.Q. Determination of 25-OH-PPD in rat plasma by high-performance liquid chromatography-mass spectrometry and its application in rat pharmacokinetic studies. J. Chromatogr. (B)., 2007, 858, 65-70.
41. Wang, W.; Zhao, Y.Q.; Rayburn, E.R.; Hill, D.L.; Wang, H.; Zhang, R.W. In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng. Cancer Chemother. Pharmacol., 2007, 59, 589-601.
42. Chen, J.T.; Li, H.Z.; Wang, D.; Zhang, Y.J.; Yang, C.R. New dammarane monodesmosides from the acidic deglycosylation of notoginseng-leaf saponins. Helvetica Chimica Acta, 2006, 89, 1442-1448.
43. Komakine, N.; Okasaka, M.; Takaishim, Y.; Kawazo, K.; Murakam, K.; Yamada, Y. New dammarane-type saponin from roots of Panax notoginseng. J. Nat. Med., 2006, 60, 135-137.
44. Wang, D.Q.; Fan, J.; Feng, B.S.; Li, S.R.; Wang, X.B.; Yang, C.R.; Zhou, J. Studies on saponins from the leaves of Panax japonicus var. bipinnatifidus seed. Yao Xue Xue Bao. 1989, 24, 593-599.
45. Dou, D.Q.; Chen, Y.J.; Liang, L.H.; Pang, F.G.; Shimizu, N.; Takeda, T. Six new dammarane-type triterpene saponins from the leaves of Panax ginseng. Chem. Pharm. Bull., 2001, 49, 442-446
46. Dou, D.Q.; Li, W.; Guo, N.; Fu, R.; Pei, Y.P.; Koike, K.Z.; Nikaido, T.T. Ginsenoside Rg8, a new dammarane-type triterpenoid saponin from roots of Panax quinquefolium. Chem. Pharm. Bull., 2006, 54, 751-753.
47. Nakamura, S.; Sugimoto, S.; Matsuda, H.; Yoshikawa, M. Medicinal flowers. XVII. New dammarane-type triterpene glycosides from flower buds of American ginseng, Panax quinquefolium L. Chem. Pharm. Bull., 2007, 55, 1342-1348.
48. Yoshikawa, M.; Sugimoto, S.; Nakamura, S.; Matsuda, H.; Medicinal flowers. XI. Structures of new dammarane-type triterpene diglycosides with hydroperoxide group from flower buds of Panax ginseng. Chem. Pharm. Bull., 2007, 55, 571-576.
49. Yoshikawa, M.; Murakami, T.; Ueno, T.; Yashiro, K.; Hirokawa, N.; Murakami, N.; Yamahara, J.; Matsuda, H.; Saijoh, R.; Tanaka, O. Bioactive saponins and glycosides. VIII. Notoginseng (1): New dammarane-type triterpene oligoglycosides, notoginsenosides-A, -B, - C, and -D, from the dried root of Panax notoginseng (Burk.) F. H. Chen. Chem. Pharm. Bull., 1997, 45, 1039-1045.
50. Yoshikawa, M.; Murakami, T.; Yashiro, K.; Yamahara, J.; Matsuda, H.; Saijoh, R.; Tanaka, O. Bioactive saponins and glycosides. XI. Structures of new dammarane-type triterpene oligoglycosides, quinquenosides I, II, III, IV, and V, from American ginseng, the roots of Panax quinquefolium L. Chem. Pharm. Bull., 1998, 46, 647-654.
51. Masayuki, Y.; Toshiyuki, M.; Takahiro, U. Biactive sapooninsand glycosides. VIII notoginseng (1):nEw dammarane-type tritrepene-oligoglycosides, notoginsenoside-A,-B,-C and -D, from the dried root of Panax notoginseng(Burk) F.H. Chen. Chem. Pharm. Bull., 1997, 45, 1039-1045.
52. Masayuki, Y.; Toshio, M.; Kenichi, Y.; Toshiyuki, M.; Hisashi, M. Bioactive Saponins and Glycosides. XIX. Notoginseng (3): Immunological adjuvant activity of notoginsenosides and related saponins: Structures of Notoginsenosides-L, -M, and -N from the Roots of Panax notoginseng. Chem. Pharm. Bull., 2001, 49, 1452-1456.
53. Qiu, F.; Ma, Z.Z.; Xu, S.X.; Yao, X.S.; Che, C.T.; Chen, Y.J. A pair of 24-hydroperoxyl epimeric dammarane saponins from flower-buds of Panax ginseng. J. Asian Nat. Prod. Res. 2001, 3, 235-240.
54. Wang, J.H.; Li, W.; Li, X. A new saponin from the leaves and stems of Panax quinquefolium L. collected in Canada. J. Asian Nat. Prod. Res. 1998, 1, 93-97.
55. Wang, J.H.; Li, W.; Sha, Y.; Tezuka, Y.; Kadota, S.; Li, X. Triterpenoid saponins from leaves and stems of Panax quinquefolium L. J. Asian Nat. Prod. Res. 2001, 3, 123-130.
56. Dou, D.; Wen, Y.; Weng, M.; Pei, Y.; Chen, Y. Minor saponins from leaves of Panax ginseng C.A. Meyer. Zhongguo Zhong Yao Za Zhi. 1997, 22, 35-37.
57. Hao, X.H.; Li, P.Y.; Li, X.; Liu, Y.Q. Saponins in the fruit of Panax quinquefolius from Canada. Zhongcaoyao, 2000, 31, 801-803.
58. Covington, M.B. Traditional Chinese Medicine in the treatment of diabetes. Diabetes Spectrum, 2001, 14, 154-159
59. Blumenthal, M. Herb sales down 15 percent in mainstream market. Herbalgram, 2001, 51, 69.
60. Tyler, V.E. The honest herbal-A sensible guide to the use of herbs and related remedies. 3rd Ed. New York: Haworth Press; 1993.
61. Vuksana, V.; Sievenpipera, J.L.; Herbal remedies in the management of diabetes: Lessons learned from the study of ginseng. Nutr. Metab. Cardiovasc. Dis. 2005, 15, 149-160.
62. Ryu, J.K.; Lee, T.; Kim, D.J.; Park, I.S.; Yoon, S.M.; Lee, H.S.; Song, S.U.; Suh, J.K. Free radical-scavenging activity of Korean red ginseng for erectile dysfunction in non-insulin-dependent diabetes mellitus rats. Urology, 2005, 65, 611-615.
63. Yoon, S.H.; Han, E.J.; Sung, J.H.; Chung, S.H. Anti-diabetic effects of compound K versus metformin versus compound K-metformin combination therapy in diabetic db/db mice. Biol. Pharm. Bull., 2007, 30, 2196-2200.
64. Attele, A.S.; Zhou, Y.P.; Xie, J.T.; Wu, J.A.; Zhang, L.; Dey, L.; Pugh, W.; Rue, P.A.; Polonsky, K.S.; Yuan, C.S. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes, 2002, 51, 1851-1858.
65. Luo, J.Z.; Luo, L. American ginseng stimulates insulin production and prevents apoptosis through regulation of uncoupling protein-2 in cultured beta-cells. Evid. Based Complement. Altern. Med., 2006, 3, 365-372.
66. Sievenpiper, J. L.; Arnason, J.T.; Leiter, L. A.; Vuksan. V. Decreasing, null and increasing effects of eight popular types of ginseng on acute postprandial glycemic indices in healthy humans: The role of ginsenosides. J. Am. Coll. Nutr., 2004, 23, 248-258.
67. Sievenpiper, J. L.; Sung, M.-K.; Di Buono, M.; Seung-Lee, K.; Nam, K. Y.; Arnason, J. T.; Leiter, L. A.; Vuksan. V. Korean red ginseng rootlets decrease acute postprandial glycemia: Results from sequential preparation- and dose-finding studies. J. Am. Coll. Nutr., 2006, 25, 100-107.
68. Vuksan, V.; Sievenpiper, J.L.; Koo, V.Y.Y.; Francis, T.; Beljan-Zdravkovic, U.; Xu, Z.; Vidgen, E. American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus. Arch. Intern. Med., 2000, 160, 1009-1013.
69. Sotaniemi, E.A.; Haapakoski, E.; Rautio, A.; Ginseng therapy in non-insulin-dependent diabetic patients. Diabetes Care, 1995, 18, 1373-1375.
70. Koshland, D.E. Jr.; The molecule of the year. Science, 1992, 258, 1861.
71. Jia, L.; Nitric oxide research and new drugs: Challenges and success. Commentary on the 1998 Nobel Prize in Medicine. Science (Chinese), 1999, 51, 49-52.
72. Jia, L.; Furchgott, R.F.; Inhibition by sulfhydryl compounds of vascular relaxation induced by nitric oxide and endothelium-derived relaxing factor. J. Pharmacol. Exp. Ther., 1993, 267, 371- 78.
73. Jia, L.; Furchgott, R.F.; Blockade of nitric oxide-induced relaxation of rabbit aorta by cysteine and homocysteine. Acta. Pharmacol. Sin., 1997, 18, 11-20.
74. Murphy, L.L.; Cadena, R.S.; Chavez, D.; Ferraro, J.S. Effect of American ginseng (Panax quinquefolium) on male copulatory behaviour in the rat. Physiol. Behav. 1998, 64, 445-450.
75. Murphy, L.L.; Lee, T.J. Ginseng, sex behavior and nitric oxide. Ann. N.Y. Acad. Sci., 2002, 962, 372-377.
76. Gillis, C.N. Panax ginseng pharmacology: A nitric oxide link? Biochem. Pharmacol., 1997, 54, 1-8.
77. Choi, H.K.; Seong, D.H.; Rha, K.H. Clinical efficacy of Korean red ginseng for erectile dysfunction. Int. J. Impot. Res., 1995, 7, 181-186.
78. Hong, B.; Ji, Y.H.; Hong, J.H.; Nam, K.Y.; Ahn, T.Y. A double-blind crossover study evaluating the efficacy of korean red ginseng in patients with erectile dysfunction: A preliminary report. J. Urol., 2002, 168, 2070-3.
79. Bahrke, M.S.; Morgan, W.P. Evaluation of the ergogenic properties of ginseng. Sports Med. 1994, 18, 229-248.
80. Chen, X.; Lee, T.J. Ginsenosides-induced a nitric oxide-mediated relaxation of the rabbit corpus cavernosum. Br. J. Pharmacol., 1995, 115, 15-18.
81. Nakaya, Y.; Mawatari, K.; Takahashi, A.; Harada, N.; Hata, A.; Yasui, S. The phytoestrogen ginsensoside Re activates potassium channels of vascular smooth muscle cells through PI3K/Akt and nitric oxide pathways. J. Med. Invest., 2007, 54, 381-384.
82. Jang, D.J.; Lee, M.S.; Shin, B.C.; Lee, Y.C.; Ernst, E. Red ginseng for treating erectile dysfunction: A systematic review. Br. J. Clin. Pharmacol. 2008, 66, 444-450.
83. Kim, S.O.; Kim, M.K.; Lee, H.S.; Park, J.K.; Park, K. The effect of Korean red ginseng extract on the relaxation response in isolated rabbit vaginal tissue and its mechanism. J. Sex Med., 2008, 5, 2079-2084.
84. Choi, Y.D.; Rha, K.H.; Choi, H.K. In vitro and in vivo experimental effect of Korean red ginseng on erection. J. Urol., 1999, 162, 1508-1511.
85. Wood, W.B.; Roh, B.L.; White, R.P. Cardiovascular actions of Panax ginseng in dogs. Jpn. J. Pharmacol., 1964, 14, 284-294.
86. Lei, X.L.; Chiou, G.C. Cardiovascular pharmacology of Panax notoginseng. Am. J. Chin. Med., 1986, 14, 145-152.
87. Kim, N.D.; Kang, S.Y.; Schini, V.B. Ginsenosides evoke endothelium-dependent vascular relaxation in rat aorta. Gen. Pharmacol., 1995, 25, 1071-1077.
88. Kang, S.Y.; Kim, S.H.; Schini, V.B.; Kim, N.D. Dietary ginsenosides improve endothelium-dependent relaxation in the thoracic aorta of hypercholesterolemic rabbit. Gen. Pharmacol., 1995, 26, 483-487.
89. Scott, G.I.; Colligan, P.B.; Ren, B.H.; Ren, J. Ginsenosides Rb1 and Re decrease cardiac contraction in adult rat ventricular myocytes: Role of nitric oxide. Br. J. Pharmacol., 2001, 134, 1159- 165.
90. Sung, J.; Han, K.H.; Zo, J.H.; Park, H.J.; Kim, C.H.; Oh, B.H. Effects of red ginseng upon vascular endothelial function in patients with essential hypertension. Am. J. Chin. Med., 2000, 28, 205-216.
91. Li, Z.; Chen, X.; Niwa, Y.; Sakamoto, S.; Nakaya, Y. Involvement of Ca2+-activated K+ channels in ginsenosides-induced aortic relaxation in rats. J. Cardiovasc. Pharmacol. 2001, 37, 41-47
92. Kim, C.S.; Park, J.B.; Kim, K.J.; Chang, S.J.; Ryoo, S.W.; Jeon, B.H. Effect of Korea red ginseng on cerebral blood flow and superoxide production. Acta Pharmacol. Sin., 2002, 23, 1152-1156.
93. Shi, L.; Fan, P.S.; Wu, L.; Fang, J.X.; Han, Z.X. Effects of total saponins of Panax notoginseng on increasing PGI2 in carotid artery and decreasing TXA2 in blood platelets. Acta Pharmacol. Sin., 1990, 11, 29-32.
94. Kimura, Y., Okuda, H.; Arichi, S. Effects of various ginseng saponins on 5-hydroxytryptamine release and aggregation in human platelets. J. Pharm. Pharmacol., 1988, 40, 838-843.
95. Park, H.J.; Lee, J.H.; Song, Y.B.; Park, K.H. Effects of dietary supplementation of lipophilic fraction from Panax ginseng on cGMP and cAMP in rat platelets and on blood coagulation. Biol. Pharm. Bull., 1996, 19, 1434-1439.
96. Jung, K.Y.; Kim, D.S.; Oh, S.R.; Lee, I.S.; Lee, J.J.; Park, J.D. Platelet activating factor antagonist activity of ginsenosides. Biol. Pharm. Bull., 1998, 21, 79-80.
97. Nakajima, S.; Uchiyama, Y.; Yoshida, K.; Mizukawa, H.; Haruki, E. The effect of ginseng radius rubra on human vascular endothelial cells. Am. J. Chin. Med., 1998, 26, 365-373.
98. Yuan, C.S.; Attele, A.S.; Wu, J.A.; Lowell, T.K.; Gu, Z.; Lin, Y. Panax quinquefolium L. Inhibits thrombin-induced endothelin release in vitro. Am. J. Chin. Med., 1999, 27, 331-338.
99. Kim, Y.M.; Namkoong, S.; Yun, Y.G.; Hong, H.D.; Lee, Y.C.; Ha, K.S.; Lee, H.; Kwon, H.J.; Kwon, Y.G.; Kim, Y.M. Water extract of Korean red ginseng stimulates angiogenesis by activating the PI3K/Akt-dependent ERK1/2 and eNOS pathways in human umbilical vein endothelial cells. Biol. Pharm. Bull., 2007, 30, 1674-1679.
100. Sengupta, S.; Toh, S.A.; Sellers, L.A.; Skepper, J.N.; Koolwijk, P.; Leung, H.W. Modulating angiogenesis: The yin and the yang in ginseng. Circulation, 2004, 7, 1219-1225.
101. Yamaguchi, Y.; Higashi, M.; Kobayashi, H. Effects of ginsenosides on impaired performance caused by scopolamine in rats. Eur. J. Pharmacol., 1996, 312, 149-151.
102. Mook-Jung, I.; Hong, H.S.; Boo, J.H.; Lee, K.H.; Yun, S.H.; Cheong, M.Y. Ginsenoside Rb1 and Rg1 improve spatial learning and increase hippocampal synaptophysin level in mice. J. Neurosci. Res., 2001, 63, 509-515.
103. Zhao, R.; McDaniel, W.F. Ginseng improves strategic learning by normal and brain-damaged rats. Neuroreport, 1998, 11, 1619-1624.
104. Zhong, Y.M.; Nishijo, H.; Uwano, T.; Tamura, R.; Kawanishi, K.; Ono, T. Red ginseng ameliorated place navigation deficits in young rats with hippocampal lesions and aged rats. Physiol. Behav., 2000, 69, 511-525.
105. Kennedy, D.O.; Scholey, A.B. Ginseng: Potential for the enhancement of cognitive performance and mood. Pharmacol. Biochem. Behav., 2003, 75, 687-700.
106. D'Angelo, L.; Grimaldi, R.; Caravaggi, M.; Marcoli, M.; Perucca, E.; Lecchini, S. A double-blind, placebo-controlled clinical study on the effect of a standardized ginseng extract on psychomotor performance in healthy volunteers. J. Ethnopharmacol., 1986, 16, 15-22.
107. Terasawa K, Shimada Y, Kita T. Choto-san in the treatment of vascular dementia: A double blind, placeb-controlled study. Phytomedicine, 1997, 4, 15-22.
108. Kurimoto H, Nishijo H, Uwano T, Yamaguchi H, Zhong YM, Kawanishi K, et al. Effects of nonsaponin fraction of red ginseng on learning deficits in aged rats. Physiol. Behav., 2004, 82, 345-355.
109. Wen, T.C.; Yoshimura, H.; Matsuda, S.; Lim, J.H.; Sakanaka, M. Ginseng root prevents learning disability and neuronal loss in gerbils with 5-minute forebrain ischaemia. Acta Neuropathol., 1996, 91, 15-22.
110. Shen, L.; Zhang, J. Ginsenoside Rg1 increases ischemia-induced cell proliferation and survival in the dentate gyrus of adult gerbils. Neurosci Lett., 2003, 344, 1-4.
111. Persson, J.; Bringlov, E.; Nilsson, L.G.; Nyberg, L. The memory enhancing effects of Ginseng and Ginkgo biloba in healthy volunteers. Psychopharmacology, 2004, 172, 430-434.
112. Sorensen, H.; Sonne, J. A double-masked study of the effect of ginseng on memory functions. Curr. Ther. Res., 1996, 57, 959-968.
113. Jia, L.; Zhao, Y.Q. Current evaluation of the millennium phytomedicine- ginseng (I): Etymology, pharmacognosy, phytochemistry, market and regulations. Curr. Med. Chem., 2009 (in press).
114. Radad, K.; Gille, G.; Liu, L. Rausch, W.D. Use of Ginseng in Medicine With Emphasis on Neurodegenerative. J. Pharmacol. Sci., 2006, 100, 175-186.
115. Kim, J.H.; Cho, S.Y.; Lee, J.H.; Jeong, S.M.; Yoon, I.S.; Lee, B.H.; Lee, J.H.; Pyo, M.K.; Lee, S.M.; Chung, J.M.; Kim, S.; Rhim, H.; Oh, J.W.; Nah, S. Neuroprotective effects of ginsenoside Rg3 against homocysteine-induced excitotoxicity in rat hippocampus. Brain Res. 2007, 1136, 190-199.
116. Sugaya, A.; Yuzurihara, M.; Tsuda, T.; Yasuda, K.; Kajiwara, K.; Sugaya, A.E. Proliferative effect of ginseng saponins on neurite extension of primary cultured neurons of the rat cerebral cortex. J. Ethnopharmacol., 1988, 22, 173-181.
117. Mizumaki, Y.; Kurimoto, M.; Hirashima, Y.; Nishijima, M.; Kamiyama, H.; Nagai, S. Lipophilic fraction of Panax ginseng induces neuronal differentiation of PC12 cells and promotes neuronal survival of rat cortical neurons by protein kinase C dependent manner. Brain Res., 2002, 20, 254-260.
118. Himi, T.; Saito, H.; Nishiyama, N. Effects of ginseng saponins on the survival of cerebral cortex neurons in cell cultures. Chem. Pharm. Bull., 1989, 37, 481-484.
119. Kim, Y.C.; Kim, S.R.; Markelonis, G.J.; Oh, Th. Ginsenosides Rb1 and Rg3 protect cultured rat cortical cells from glutamate-induced neurodegeneration. J. Neurosci. Res., 1998, 4, 426-432.
120. Liao, B.; Newmark, H.; Zhou, R. Neuroprotective effects of ginseng total saponins and ginsenosides Rb1 and Rg1 on spinal cord neurons in vitro. Exp. Neurol., 2002, 173, 224-234.
121. Chang, y.; Wang, S.J. Ginsenoside Rg1 and Rb1 enhance glutamate exocytosis from rat cortical nerve terminals by affecting vesicle mobilization through the activation of protein kinase C. Eur. J. Pharmacol., 2008, 590, 74-79.
122. Chang, Y.; Huang, W.J.; Tien, L.T.; Wang, S.J. Ginsenosides Rg1 and Rb1 enhance glutamate release through activation of protein kinase A in rat cerebrocortical nerve terminals (synaptosomes) Eur. J. Pharmacol., 2008, 578, 28-36.
123. Tanner, C.M.; Ben-Schlomo, Y. Epidemiology of Parkinson's disease. Adv. Neurol., 1999, 80, 153-159.
124. Van Kampen, J.; Robertson, H.; Hagg, T.; Drobitch, R. Neuro-protective actions of the ginseng extract G115 in two rodent models of Parkinson's disease. Exp. Neurol., 2003, 184, 21-29.
125. Tohda, C.; Matsumoto, N.; Zou, K.; Meselhy, M.R.; Komatsu, K. Axonal and dendritic extension by protopanaxadiol-type saponins from ginseng drugs in SK-N-SH cells. Jpn. J. Pharmacol., 2002, 90, 254-262.
126. Tsang, D.; Yeung, H.W.; Tso, W.W.; Peck, H. Ginseng Saponins: Influence on neurotransmitter uptake in rat brain synaptosomes. Planta Med., 1985, 3, 221-224.
127. Nah, S.Y.; Bhatia, K.S.; Lyles, J.; Ellinwood, E.H.; Lee, T.H. Effects of ginseng saponin on acute cocaine-induced alterations in evoked dopamine release and uptake in rat brain nucleus accumbens. Brain Res., 2009. doi:10.1016/j.brainres.2008.10.064.
128. Yance, D.R. Jr.; Sagar, S.M. Targeting angiogenesis with integrative cancer therapies. Integr. Cancer Ther., 2006, 5, 9-29.
129. Jia, L. Chemistry, pharmacology, toxicity and clinical uses of Tripterygium Wilfordii. Chin. Pharmaceu. Bull., 1985, 20, 101-106.
130. Shoemaker, M.; Hamilton, B.; Dairkee, S.H.; Cohen, I.; Campbell, M.J. In vitro anticancer activity of twelve Chinese medicinal herbs. Phytother. Res., 2005, 19, 649-651.
131. Rugo, H.; Shtivelman, E.; Perez, A.; Vogel, C.; Franco, S.; Tan, C.E.; Melisko, M.; Tagliaferri, M.; Cohen, I.; Shoemaker, M.; Tran, Z.; Tripathy, D. Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer. Breast Cancer Res. Treat., 2007, 105(1), 17-28.
132. Jia, L.; Coward, L.C.; Kerstner-Wood.; Gorman, G.; Noker, P.; Kitada, S.; Pellecchia, M. P.; Reed, J.C. Comparison of pharmacokinetic and metabolic profiling among gossypol, apogossypol and apogossypol hexaacetate. Cancer Chemother. Pharmacol., 2008, 61, 63-73.
133. Shin, H.R.; Kim, J.Y.; Yun, T.K.; Morgan, G.; Vainio, H. The cancer-preventive potential of Panax ginseng: A review of human and experimental evidence. Cancer Causes Control., 2000, 11, 565-576.
134. Helms, S. Cancer prevention and therapeutics: Panax ginseng. Altern. Med. Rev., 2004, 9, 259-74.
135. Yun, T.K. Update from Asia. Asian studies on cancer chemoprevention. Ann. N. Y. Acad. Sci., 1999, 889, 157-192.
136. Block, K.I.; Mead, M.N. Immune system effects of echinacea, ginseng, and astragalus: A review. Integr. Cancer Ther., 2003, 2, 247-67.
137. Shibata, S. Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds. J. Korean Med. Sci., 2001, 16, S28-S37.
138. Sengupta, S.; Toh, S.A.; Sellers, L.A.; Skepper, J.N.; Koolwijk, P.; Leung, H.W.; Yeung, H.W.; Wong, R.N.S.; Sasisekharan, S.; Fan, T.P.D. Modulating Angiogenesis The Yin and the Yang in Ginseng. Circulation, 2004, 110, 1219-1225.
139. Yue, P.Y.; Mak, N.K.; Cheng, Y.K.; Leung, K.W.; Ng, T.B.; Fan, D.T.; Yeung, H.W.; Wong, R.N. Pharmacogenomics and the Yin/Yang actions of ginseng: Anti-tumor, angiomodulating and steroid-like activities of ginsenosides. Chin Med., 2007, 2, 1-21.
140. Hofseth, L.J.; Wargovich, M.J. Inflammation, cancer, and targets of ginseng. J. Nutr., 2007, 137(1 Suppl),183S-185S.
141. Zhao, Y.; Wang, W.; Han, L.; Rayburn, E.R.; Hill, D.L.; Wang, H.; Zhang, R. Isolation, structural determination, and evaluation of the biological activity of 20(S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol [20(S)-25-OCH3-PPD], a novel natural product from Panax notoginseng. Med. Chem. 2007, 3, 51-60.
142. Wang, W.; Wang, H.; Rayburn, E.R.; Zhao, Y.; Hill, D.L.; Zhang, R. 20(S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol, a novel natural product for prostate cancer therapy: Activity in vitro and in vivo and mechanisms of action. Br. J. Cancer, 2008, 98, 792-802.
143. Jin, Y.; Kotakadi, V.S.; Ying, L.; Hofseth, A.B.; Cui, X.; Wood, P.A.; Windust, A.; Matesic, L.E.; Pena, E,A.; Chiuzan, C.; Singh, N.P.; Nagarkatti, M.; Nagarkatti, P.S.; Wargovich, M.J.; Hofseth, L.J. American ginseng suppresses inflammation and DNA damage associated with mouse colitis. Carcinogenesis, 2008, 29, 2351-9
144. Niu, Y.P.; Gao, R.; Helen, T. Study on induction of ginsenosides on HL-60 cell apoptosis. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2002, 22, 450-452.
145. Xing, J.H.; Chen, Y.Q.; Ji, M.X. Clinical study on effect of ginsenoside in inducing rectal cancer cell apoptosis. Chin. J. Integr. Med., 2001, 21, 260-261.
146. Park, J.A.; Lee, K.Y.; Oh, Y.J. Activation of caspase-3 protease via a Bcl222insensitive pathway during the process of ginsenoside Rh2-induced apoptosis. Cancer Lett., 1997, 121, 73-81
147. Jin, Y.H.; Yoo, K. J.; Lee, Y. H. Caspase 3mediated cleavage of p21WAF1/ CIP1 associated with the cyclin A2cy2 clin2dependent kinase 2 complex is a prerequisite for apoptosis in SK2HEP21 cells. J. Biol. Chem., 2000, 275, 30256-30263.
148. Kim, Y.S.; Jin, S. H.; Lee, Y. H. Differential expression of protein kinase C subtypes during ginsenoside Rh2 induced apoptosis in SK2N2BE(2) and C6Bu21 cells. Arch. Pharm. Res., 2000, 23, 518-524.
149. Fei, X.F.; Wang, B.X.; Tashiro, S.; Li, T.J.; Ma, J.S.; Ikejima, T. Apoptotic effects of ginsenoside Rh2 on human malignant melanoma A375-S2 cells. Acta. Pharmacol. Sin., 2002, 23, 315-322.
150. Tran, Q.; Tezuka, Y.; Banskota, A. H.; Tran, Q.K. New spirostanol steroids and steroidal saponins from roots and rhizomes of Dracaena angustifolia and their antiproliferative activity. J. Nat. Prod., 2001, 64, 1127-1132.
151. Nakata, H.; Kikuchi, Y.; Tode, T. Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells. Jpn. J. Cancer Res., 1998, 89, 733-740.
152. Cheng, C,C.; Yang, S.M.; Huang, C.Y.; Chen, J.C.; Chang, W.M.; Hsu, S.L. Molecular mechanisms of ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells. Cancer Chemother. Pharmacol., 2005, 55, 531-540.
153. Jiang, H.; Fan, G. H. Efficacy of ginsenoside-Ph2 on proliferation and apoptosis for Bel-7404 cell line. Chin. J. Clin. Oncol. Rehabil, 2004, 11, 289-293.
154. Oh, M.; Choi, Y.H.; Choi, S. Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells. Int. J. Oncol. 1999, 14, 869-875.
155. Liu, W.K.; Xu, S.X.; Che, C.T. Anti-proliferative effect of ginseng saponins on human prostate cancer cell line. Life Sci., 2000, 67, 1297-1306.
156. Li, X.; Guan, Y.S.; Zhou, X.P. Anticarcinogenie effect of 20(R)-ginsenodide-Rg3 on induced hepatocellullar carcinoma in rats. J. Sichuan Univ. (Med Sci Edi), 2005, 36, 217-220.
157. Yun, T.K.; Lee, Y.S.; Lee, Y.H. Anticarcinogenic effect of Panax ginseng C.A. Meyer and identification of active compounds. J. Korean Med. Sci., 2001, 16, S6-S18.
158. Bespalov, V.G.; Alexandrov, V.A.; Limarenko, A.Y. Chemoprevention of mammary, cervix and nervous system carcinogenesis in animals using cultured Panax ginseng drugs and preliminary clinical trials in patients with precancerous lesions of the esophagus and endometrium. J, Korean. Med. Sci., 2001, 16, S42-S53.
159. Xu, T.M.; Xin, Y.; Cui, M.H.; Jiang, X.; Gu, L.P. Inhibitory effect of ginsenoside Rg3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer. Chin. Med. J., 2007, 120, 584-588.
160. Chen, J.X.; Peng, H.M.; Pu, S.P.; Guo, Y.P. Inducement effect of ginsenoside Rg3 on apoptosis of human bladder transitional cell carcinoma cell line EJ. Zhongguo Zhong Yao Za Zhi. 2007, 32, 1680-1684.
161. Oh S, Lee B H.A ginseng saponin metabolite-induced apoptosis in HepG2 cells involves a mitochondria-mediated pathway and its downstream caspase-8 activation and Bid cleavage. Tox. Appl. Pharmacol., 2004, 194(3), 221-229.
162. Choi, H.H.; Jong, H.S.; Jung, H.; Choi, S. A novel ginseng saponin metabolite induces apoptosis and down-regulates fibroblast growth factor receptor 3 in myeloma cells. Int. J. Oncol., 2003, 23, 1087-1093.
163. Lee, S.J.; Ko, W.G.; Kim, J.H. Induction of apoptosis by a novel intestinal metabolite of ginseng saponin via cytochrome c-mediated activation of caspase-3 protease. Biochem. Pharmacol., 2000, 60, 677-685.
164. Suda K, Murakami K. Induction of apoptosis in Lewis lung carcinoma cells by an intestinal bacterial metabolite produced from orally administered ginseng protopanaxadiol saponins. J. Trad. Med., 2000, 17, 236-244.
165. Hasegawa, H.; Uchiyama, M. Antimetasatic efficacy of orally administered ginsenoside Rb1 in dependence no intestinal bacterial hydrolyzing potential and significance of treatment with an active bacterial metabolite. Planta Med., 1998, 64, 696-700.
166. Hideo, H.; Jong, H.S.; Jae, D.H. Ginseng intestinal bacterial metabolite IH901 as a new antimetastatic agent. Arch. Pharm. Res., 1996, 6, 539-544.
167. Yim, H.W.; Jong, H. S.; Kim, T.Y. Cyclooxygenase-2 inhibits novel ginseng metabolite-mediated apoptosis. Cancer Res., 2005, 65, 1952-1960.
168. Kim, S.E.; Lee, Y.H.; Park, J.H. Ginsenoside-Rs4, a new type of ginseng saponin concurrently induces apoptosis and selectively elevates protein levels of p53 and p21WAF1 in human hepatoma SK-HEP-1 cells. Eur. J. Cancer, 1999, 35, 507-511.
169. Wskabayashi, C.; Murakami, K.; Hasegava, H. An intestinal bacterial metabolite of ginseng protopanaxadiol saponins has the ability to induce apoptosis in tumor cells. Biochem. Biophys. Res. Commun, 1998, 246, 725-730.
170. Park, I.H.; Piao, L.Z.; Kwon, S.W. Cytotoxic dammarane glycosides from processed ginseng. Chem. Pharm. Bull., 2002, 50, 538-540.
171. Lee, K.Y.; Lee, S.K. Ginsenoside-Rg5 supresses cyclin E-dependent protein kinase activity via up-regulation of p21Waf1 with concomitant down-regulation of cdc25A in SK-HEP-1 Cells. Anticancer Res., 1997, 17, 1067-1072.
172. Liu, X.D.; Jia, L. The conduct of drug metabolism studies considered good practice (I): Analytical systems and in vivo studies. Curr. Drug Metab., 2007, 8, 815-821.
173. Takino, Y.; Odani, T.; Hisayuki, T.; Hayashi, T. Studies on the absorption, distribution, excretion and metabolism of ginseng saponins I. Quantitative analysis of ginsenoside Rg1 in rats. Chem. Pharm. Bull., 1982, 30, 2196-2210.
174. Kajiwara, H.; Hewmming, A.M.; Hirano, H. Evidence of metal binding activities of pentadecapeptid from Panax ginseng. J. Chromatogr., 1996, 687, 443-448.
175. Andrade, A.S.; Hendrix, C.; Parsons, T.L.; Caballero, B.; Yuan, C.S.; Flexner, C.W.; Dobs, A.S.; Brown, T.T. Pharmacokinetic and metabolic effects of American ginseng (Panax quinquefolius) in healthy volunteers receiving the HIV protease inhibitor indinavir. BMC Complement. Altern. Med., 2008, 8, 50-59.
176. Hess, F.G.Jr.; Parent, R.A.; Stevens, K.R.; Cox, G.E.; Becci, P.J. Effects of subchronic feeding of ginseng extract G115 in beagle dogs. Food Chem. Toxicol., 1983, 21, 95-97.
177. Siegel, R.K. Ginseng abuse syndrome-problems with the panacea. JAMA, 1979, 241, 1614-1615.
178. Klepser, T.B.; Klepser, M.E. Unsafe herbal therapies. Am. J. Health System Pharm., 1999, 56, 125.
179. Kitts, D.D.; Hu, C. Efficacy and safety of ginseng. Pub. Health Nutrition, 2000, 3, 473-485.
180. Coon, J.T.; Ernst, E. Panax ginseng: A systematic review of adverse effects and drug interactions. Drug Saf., 2002, 25, 323-344.
181. Janetzky, K.; Morreale, A.P. Probable interactions between warfarin and ginseng. Am. J. Health Syst. Pharm., 1997, 54, 692-693.